A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are to:
- Evaluate the potential effects of PPI-668 at steady state on the pharmacokinetic (PK)
profile of midazolam following a single oral dose in human subjects.
- Evaluate the potential effects of PPI-668 at steady state on the PK profile of
omeprazole following a single oral dose in human subject